Effects of Nature and Forest Therapy in Patients With Metabolic Syndrome and Cardiovascular Risk Factors
NCT ID: NCT04781491
Last Updated: 2023-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2022-06-27
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Physical Activity on the Brain in Impaired Glucose Tolerance (IGT)
NCT01219231
Effect of Physical Activity and Diet on the Treatment of Metabolic Syndrome
NCT00917917
Effects of 3 Months of Supervised Exercise Training
NCT01349166
RESIST! Blood-flow Restriction Resistance Training for Improving Insulin Sensitivity in Type 2 Diabetes
NCT04222231
Normobaric Hypoxic Training and Metabolic Syndrome
NCT01468220
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main objective of this study is to measure the effects of nature and forest therapy in subjects with manifest metabolic syndrome and cardiovascular risk factors. The intervention is a stay in the nature of the Düppeler Forest (Berlin-Wannsee) under the guidance of trained nature guides (90 minutes, 1x/week over 2 months), who teach exercises on the perception of nature and the connection between nature and health, movement and mindfulness. Subjects are also motivated to experience forest nature as regularly as possible (recommended ≥ 30 minutes daily). Participants of the control group will be offered a later participation in the therapy program after completion of the last study visit after 4 months (waiting list control group).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Forest Therapy (Düppeler Forst - Berlin-Wannsee)
Subjects receive a 90-minute Forest Therapy session once per week for 8 weeks with a licensed nature therapist, who explains exercises on perceiving nature and the connection between nature and health.
Forest Therapy (Düppeler Forst - Berlin-Wannsee)
Forest Therapy means mindful visits in nature, actively perceiving the flora and fauna
Waiting list
Subjects don't receive any therapy but are offered the same treatment after trial is finished.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Forest Therapy (Düppeler Forst - Berlin-Wannsee)
Forest Therapy means mindful visits in nature, actively perceiving the flora and fauna
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* waist circumference: at least 94 cm for men, at least 80 cm for women
* plus at least two of the following risk factors:
* fasting blood glucose levels of \> 100 mg/dl (\> 5.6 mmol/l) measured in blood plasma or diagnosed diabetes mellitus
* elevated triglycerides \> 150 mg/dl (\> 1.7 mmol/l) or therapy already initiated to lower triglycerides
* low HDL cholesterol: \< 40 mg/dl (\< 1.05 mmol/l) in men and \< 50 mg/dl (\< 1.25 mmol/l) in women or already initiated therapy to increase HDL
* Hypertension (from \> 130 mmHg systolic and \> 85 mmHg diastolic) or already treated hypertension
Exclusion Criteria
* Immobility or limitation of mobility due to orthopedic, neurological or other medical cause
* Participation in another study
* Serious mental illness
* Pregnancy and lactation
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreas Michalsen
Prof.Dr.med
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Michalsen, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Wald
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.